Pancreatic Cancer Research

ResearcherMassachusetts Institute of TechnologyActive in the last 2 years

Miles Aaron Miller

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7638-8898; OpenAlex author ID A5047564466. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in pancreatic ductal adenocarcinoma Last author DOI 10.21203/rs.3.rs-6606556/v1↗
  2. ADAM8 as a drug target in pancreatic cancer. Co-author DOI 10.1038/ncomms7175↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Lagares · 1 shared paper, 2026 · strength 0.29
  2. Ahmed M. R. H. Mostafa · 1 shared paper, 2026 · strength 0.29
  3. Praneeth Reddy Kuninty · 1 shared paper, 2026 · strength 0.29
  4. Jai Prakash · 1 shared paper, 2026 · strength 0.29
  5. Uwe Schlomann · 1 shared paper, 2015 · strength 0.04
  6. Rozita Roshani · 1 shared paper, 2015 · strength 0.04
  7. Thorsten Hagemann · 1 shared paper, 2015 · strength 0.04
  8. David Arthur Tuveson · 1 shared paper, 2015 · strength 0.04
  9. Jörg Walter Bartsch · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.